Novel Drug Prevents Common Viral Disease in Stem-Cell Transplant Patients – Science Daily (press release)
|
Novel Drug Prevents Common Viral Disease in Stem–Cell Transplant Patients
Science Daily (press release) Sep. 25, 2013 — A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s … Novel Antiviral Blocks CMV After Stem Cell TxMedPage Today Antiviral Protects Against CMV After Stem Cell TransplantsMedscape Chimerix Announces Publication of Positive Phase 2 Results of Brincidofovir …MarketWatch Healio all 9 news articles |
